Bliss GVS Pharma Limited

NSE:BLISSGVS.NS

124.26 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 2,176.7951,836.4271,981.2832,007.1832,118.7711,595.2121,847.792,057.171,724.2991,886.6161,575.3782,162.5791,959.8741,681.4541,235.3551,640.6141,515.4061,295.51,124.0491,478.4892,101.2422,115.322,319.112,204.3482,284.3012,023.4291,672.6051,958.8842,262.8762,252.0752,582.9882,321.9781,691.0091,401.4341,435.5641,323.8351,760.726948.8161,486.443813.1681,029.227637.416
Cost of Revenue 1,149.2551,185.2761,268.2671,024.867997.352844.261,089.8671,013.883957.751951.748870.1871,112.4491,059.584867.6764.009918.848811.864794.369705.603815.3841,558.3021,320.4451,728.6131,471.2681,564.5961,358.088760.582791.2111,251.771,107.708951.9961,256.944727.253657.218755.788314.294855.02335.013724.747412.79563.739336.824
Gross Profit 1,027.54651.151713.016982.3161,121.419750.952757.9231,043.287766.548934.868705.1911,050.13900.29813.854471.346721.766703.542501.131418.446663.105542.94794.875590.497733.08719.705665.341912.0231,167.6731,011.1061,144.3671,630.9921,065.034963.756744.216679.7761,009.541905.706613.803761.696400.378465.488300.592
Gross Profit Ratio 0.4720.3550.360.4890.5290.4710.410.5070.4450.4960.4480.4860.4590.4840.3820.440.4640.3870.3720.4490.2580.3760.2550.3330.3150.3290.5450.5960.4470.5080.6310.4590.570.5310.4740.7630.5140.6470.5120.4920.4520.472
Reseach & Development Expenses 00152.297000125.628000131.0120000000000000000000000000000000
General & Administrative Expenses 0076.48000190.861000217.533000213.936000159.192000230.75700000000000212.4480000000
Selling & Marketing Expenses 00421.525000279.592000268.09000122.177000125.248000204.75200000000000318.5070000000
SG&A 337.704376.333498.005302.493345.116235.212470.453345.024311.418205.521485.623192.816189.368290.443336.113173.521157.228160.323284.44140.954143.232114.925435.509111.169101.61299.46589.306177.284170.435173.745240.833166.482138.321108.101530.95575.60799.74175.4730000
Other Expenses 682.58541.22755.99554.229126.01851.13229.77956.46521.51170.109-167.55260.36354.578.172-111.56741.15227.4170.415-190.60455.165128.96321.104-342.689-39.02248.749138.672530.004729.303433.565519.379908.653633.372571.524299.414175.175683.665451.791230.099586136.34399.14753.185
Operating Expenses 682.585376.333498.005614.917641.648570.705744.362612.815567.1591.857375.582752.784649.174511.181329.371382.603426.621349.224263.218363.391323.251333.001181.868319.626327.817281.042530.004729.303433.565519.379908.653633.372571.524299.414175.175683.665451.791230.099586136.34399.14753.185
Operating Income 344.955274.818215.011421.628605.789180.24743.34486.937220.959343.011162.022297.346251.116302.673141.975339.163276.921151.907155.228299.714219.689461.874408.629413.454391.888384.299382.019438.37577.541624.988722.339431.662392.232444.802504.601325.876453.915383.704175.696264.035366.341247.407
Operating Income Ratio 0.1580.150.1090.210.2860.1130.0230.2370.1280.1820.1030.1370.1280.180.1150.2070.1830.1170.1380.2030.1050.2180.1760.1880.1720.190.2280.2240.2550.2780.280.1860.2320.3170.3520.2460.2580.4040.1180.3250.3560.388
Total Other Income Expenses Net 12.10825.917-254.497-21.179-14.49136.212-50.843-12.609-19.05348.974102.52-685.95847.74864.18623.8431.71423.61252.138-21.89744.407118.45112.185-92.65-48.651236.062126.1-396.439-47.21-61.535-64.815-78.72-36.315-43.69-40.52-71.58-17.469-46.068-51.03284.776-22.046-13.33-8.057
Income Before Tax 357.063300.735-39.486400.449591.298216.459-7.503474.328201.906391.985264.542-388.612298.864366.859165.815370.877300.533204.045133.331344.121338.14474.059315.979364.803627.95510.399-14.42391.16516.006560.173643.619395.347348.542404.282433.021308.407407.847332.672260.472241.989353.011239.35
Income Before Tax Ratio 0.1640.164-0.020.20.2790.136-0.0040.2310.1170.2080.168-0.180.1520.2180.1340.2260.1980.1580.1190.2330.1610.2240.1360.1650.2750.252-0.0090.20.2280.2490.2490.170.2060.2880.3020.2330.2320.3510.1750.2980.3430.376
Income Tax Expense 100.13879.6679.649109.724160.85472.714-43.978176.44541.887117.18829.87396.69878.272105.54584.2995.29584.4337.53977.61789.60729.512140.387128.10792.516211.297120.584122.757131.327121.023191.161179.865165.826152.851129.866146.02773.721127.753132.991174.404148.102106.07270.401
Net Income 242.604206.974-91.477276.102423.065146.85133.438279.419138.538257.193196.32-501.122212.662242.54262.421255.506205.062161.9287.472237.458309.813337.907181.076258.362414.563383.215-143.155179.207339.877211.924368.704144.35136.502206.549176.83222.145230.424195.42667.42393.887246.939168.949
Net Income Ratio 0.1110.113-0.0460.1380.20.0920.0180.1360.080.1360.125-0.2320.1090.1440.0510.1560.1350.1250.0780.1610.1470.160.0780.1170.1810.189-0.0860.0910.150.0940.1430.0620.0810.1470.1230.1680.1310.2060.0450.1150.240.265
EPS 2.311.97-0.882.644.051.40.322.681.332.481.89-4.832.052.350.612.481.571.570.852.333.281.762.54.021.76-1.391.744.932.053.212.022.462.671.712.152.231.890.650.912.391.64
EPS Diluted 2.291.93-0.862.63.981.380.322.641.312.441.82-4.832.012.290.612.431.541.540.852.333.281.762.54.021.76-1.391.744.932.053.212.022.462.671.712.152.231.890.650.912.391.64
EBITDA 465.144343.309283.477491.163669.701293.26492.183533.324266.961458.621475.377402.017348.582424.186235.607423.944347.448265.187340.694384.623383.624510.733453.861396.373664.023545.039430.762503.95626.183675.852733.527529.417448.447480.829521.479352.101512.994414.121203.643274.621377.388258.081
EBITDA Ratio 0.2140.1870.1430.2450.3160.1840.050.2590.1550.2430.3020.1860.1780.2520.1910.2580.2290.2050.3030.260.1830.2410.1960.180.2910.2690.2580.2570.2770.30.2840.2280.2650.3430.3630.2660.2910.4360.1370.3380.3670.405